Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Accounts Payables (2022 - 2025)

Envoy Medical's Accounts Payables history spans 4 years, with the latest figure at $2.9 million for Q4 2025.

  • Quarterly results put Accounts Payables at $2.9 million for Q4 2025, up 76.76% from a year ago — trailing twelve months through Dec 2025 was $2.9 million (up 76.76% YoY), and the annual figure for FY2025 was $2.9 million, up 76.76%.
  • Accounts Payables for Q4 2025 was $2.9 million at Envoy Medical, up from $2.7 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $3.4 million in Q3 2023 to a low of $658899.0 in Q1 2022.
  • The 4-year median for Accounts Payables is $1.6 million (2023), against an average of $1.6 million.
  • The sharpest move saw Accounts Payables surged 215.59% in 2023, then crashed 48.03% in 2024.
  • Year by year, Accounts Payables stood at $1.0 million in 2022, then skyrocketed by 54.94% to $1.6 million in 2023, then increased by 6.31% to $1.7 million in 2024, then soared by 76.76% to $2.9 million in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $2.9 million, $2.7 million, and $1.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.